Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John L Cleveland

Showing results (121-130 of 152) with videos related to

Pageof 16
Sort By:
The Journal of Urology|May 21, 2019
African American Specific Gene Panel Predictive of Poor Prostate Cancer OutcomeMichelle I Echevarria, Shivanshu Awasthi, Chia-Ho Cheng, et al.
Prostate Cancer and Prostatic Diseases|October 28, 2018
Distinct transcriptional repertoire of the androgen receptor in ETS fusion-negative prostate cancerAnders E Berglund, Robert J Rounbehler, Travis Gerke, et al.
Frontiers in Immunology|June 21, 2018
Distinct Immunomodulatory Effects of Spermine Oxidase in Colitis Induced by Epithelial Injury or InfectionAlain P Gobert, Nicole T Al-Greene, Kshipra Singh, et al.
Molecular Cell|August 23, 2011
Hsp90-Cdc37 chaperone complex regulates Ulk1- and Atg13-mediated mitophagyJoung Hyuck Joo, Frank C Dorsey, Aashish Joshi, et al.
Medrxiv : the Preprint Server for Health Sciences|July 10, 2026
Hematopoietic mosaic chromosomal alterations are pleiotropic drivers of inflammaging, multimorbidity, and mortalityNicole D Vincelette, Qianxing Mo, Chia-Ho Cheng, et al.
Oncogene|May 1, 2020
Spermine oxidase mediates Helicobacter pylori-induced gastric inflammation, DNA damage, and carcinogenic signalingJohanna C Sierra, M Blanca Piazuelo, Paula B Luis, et al.
Blood|October 15, 2016
The NLRP3 inflammasome functions as a driver of the myelodysplastic syndrome phenotypeAshley A Basiorka, Kathy L McGraw, Erika A Eksioglu, et al.
Cell Reports|March 17, 2021
Transcriptional programming drives Ibrutinib-resistance evolution in mantle cell lymphomaXiaohong Zhao, Michelle Y Wang, Huijuan Jiang, et al.
Blood|July 31, 2020
TP53 mutations in myelodysplastic syndromes and secondary AML confer an immunosuppressive phenotypeDavid A Sallman, Amy F McLemore, Amy L Aldrich, et al.
JCI Insight|April 8, 2020
Metabolic reprogramming augments potency of human pSTAT3-inhibited iTregs to suppress alloreactivityKelly Walton, Mario R Fernandez, Elizabeth M Sagatys, et al.
Pageof 16

Showing results (121-130 of 152) with videos related to

Sort By:
Pageof 16
The Journal of Urology|May 21, 2019
African American Specific Gene Panel Predictive of Poor Prostate Cancer OutcomeMichelle I Echevarria, Shivanshu Awasthi, Chia-Ho Cheng, et al.
Prostate Cancer and Prostatic Diseases|October 28, 2018
Distinct transcriptional repertoire of the androgen receptor in ETS fusion-negative prostate cancerAnders E Berglund, Robert J Rounbehler, Travis Gerke, et al.
Frontiers in Immunology|June 21, 2018
Distinct Immunomodulatory Effects of Spermine Oxidase in Colitis Induced by Epithelial Injury or InfectionAlain P Gobert, Nicole T Al-Greene, Kshipra Singh, et al.
Molecular Cell|August 23, 2011
Hsp90-Cdc37 chaperone complex regulates Ulk1- and Atg13-mediated mitophagyJoung Hyuck Joo, Frank C Dorsey, Aashish Joshi, et al.
Medrxiv : the Preprint Server for Health Sciences|July 10, 2026
Hematopoietic mosaic chromosomal alterations are pleiotropic drivers of inflammaging, multimorbidity, and mortalityNicole D Vincelette, Qianxing Mo, Chia-Ho Cheng, et al.
Oncogene|May 1, 2020
Spermine oxidase mediates Helicobacter pylori-induced gastric inflammation, DNA damage, and carcinogenic signalingJohanna C Sierra, M Blanca Piazuelo, Paula B Luis, et al.
Blood|October 15, 2016
The NLRP3 inflammasome functions as a driver of the myelodysplastic syndrome phenotypeAshley A Basiorka, Kathy L McGraw, Erika A Eksioglu, et al.
Cell Reports|March 17, 2021
Transcriptional programming drives Ibrutinib-resistance evolution in mantle cell lymphomaXiaohong Zhao, Michelle Y Wang, Huijuan Jiang, et al.
Blood|July 31, 2020
TP53 mutations in myelodysplastic syndromes and secondary AML confer an immunosuppressive phenotypeDavid A Sallman, Amy F McLemore, Amy L Aldrich, et al.
JCI Insight|April 8, 2020
Metabolic reprogramming augments potency of human pSTAT3-inhibited iTregs to suppress alloreactivityKelly Walton, Mario R Fernandez, Elizabeth M Sagatys, et al.
Pageof 16